Sateesh Natarajan, Ph.D., is Silverback’s vice president of CMC development. He has more than 20 years of research and development experience, spanning from design and discovery of small and large molecule drugs to CMC development. Most recently, he served as the vice president, product development at Dr. Reddy’s Laboratories, where he provided strategic and technical leadership for global development of biosimilar products. His prior experience includes leading research and development efforts at Dendreon and Trubion to advance novel therapies for oncology and inflammatory disorders. He received his Ph.D. in Chemical and Biochemical Engineering from The University of Maryland, Baltimore County, and followed it with a post-doctoral position in Immunology and Biophysical Chemistry at The Johns Hopkins School of Medicine.